NCT07862335

Evaluating Autologous Platelet-Rich Fibrin Plasma for Chronic Lower Extremity Ulcers

RecruitingPHASE1, PHASE2INTERVENTIONAL

Trial Details

Start: 2026-09Est. Completion: 2027-06

Enrollment target: 30 participants

Contact

Hereditary Hemorrhagic TelangiectasiaEpistaxisAnemiaNosebleedHHT

During the Efficacy Study (Part B), the investigators will study whether Pazopanib, taken daily for 24 weeks, will reduc…

Los Angeles, United StatesCompleted Nov 21, 2025

Multiple Sclerosis Spasticity

The purpose of this study is to evaluate the efficacy, safety, and tolerability of BMS-986368 in participants with Multi…

Birmingham, United StatesEst. completion May 26, 2027

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.